Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:16 PM
Ignite Modification Date:
2025-12-24 @ 7:16 PM
NCT ID:
NCT03961503
Eligibility Criteria:
Inclusion criteria:
* Patient older than 18 years
* Admitted in ICU from January 2010 to December 2012
* Suspected or proven cardiac, vascular or profound surgical site infection with Gram-positive cocci (GPC) methicillin-resistant (MR) strains (including probabilistic treatment for patients with acquisition of MR risk factors)
* Treatment duration greater than or equal to 48 hours (at least 2 doses of daptomycin administered or 2 days of vancomycin infusion)
* Antibiotic treatment started in peri-operative (from 48 hours before the onset of surgery) or in postoperative period (during ICU stay)
Exclusion criteria:
* Prophylaxis indication of antibiotics
* Kidney disease on chronic dialysis
* Acute onset of RRT before initiation of DAP or VAN treatment
* Staphylococcus pneumonia
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03961503
Study Brief:
Protocol Section:
NCT03961503